Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-24
1998-06-16
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 514 2, 530317, 930270, A61K 3813, C07K 764
Patent
active
057670692
ABSTRACT:
Nonimmunosuppressant cyclosporin derivatives having cyclophilin-binding useful in inhibiting HIV-1 replication in treating AIDS and AIDS related disorders.
REFERENCES:
patent: 4639434 (1987-01-01), Wenger et al.
patent: 4771122 (1988-09-01), Seebach
patent: 4798823 (1989-01-01), Witzel
patent: 4814323 (1989-03-01), Andrieu et al.
patent: 5122511 (1992-06-01), Patchett et al.
Durette et al, Transplantation Proceedings, vol. 44, No. 2, Seyyl. 2 (Apr., 1988) pp. 51-57.
Wenger, Sandorama, (1984), pp. 5-11.
Rosenwirth, et al., Antimicrobial Agents and Chemotherapy 1994, vol. 38, No. 8 pp. 1763-1772.
Billich, et al., Journal of Virology, Apr. 1995, pp. 2451-2461 --vol. 69, No. 4.
Steinkasserer, et al., Journal of Virology, Feb. 1995, pp. 814-824--vol. 69, No. 2.
Thali, et al., Letters to Nature--vol. 372--24 Nov. 1994.
Besemer-Rosenwirth Brigitte
Bollinger Pietro
Ko Soo Young
Kobel Hans
Seebach Dieter
Achutamurthy Ponnathapura
Mathias Marla J.
McGovern Thomas O.
Novartis AG
Wessendorf T. D.
LandOfFree
Cyclosporins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclosporins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726021